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Introduction
Protein conformational disorders are associated with the mis-
folding and aggregation of proteins into cross-β-sheet structures 
called amyloid.1 Interestingly, these disorders may result from 
a common underlying mechanism that has been described as 
prion-like.2 Prions are proteins that form a self-propagating, amy-
loid-like structure that converts protein from its native state into 
the prion conformation.3 When the mammalian protein PrP mis-
folds to its prion conformation, it is infectious. This infectious 
prion protein is the causative agent of one class of mammalian 
protein conformational disorders called transmissible spongiform 
encephalopathies. While the term amyloid is traditionally used in 
the context of cellular dysfunction and disease, many examples of 
amyloid structures with normal cellular functions are emerging 
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The formation of fibrillar amyloid is most often associated 
with protein conformational disorders such as prion diseases, 
Alzheimer disease and Huntington disease. Interestingly, 
however, an increasing number of studies suggest that amyloid 
structures can sometimes play a functional role in normal 
biology. Several proteins form self-propagating amyloids 
called prions in the budding yeast Saccharomyces cerevisiae. 
These unique elements operate by creating a reversible, 
epigenetic change in phenotype. While the function of the 
non-prion conformation of the Rnq1 protein is unclear, the 
prion form, [RNQ+], acts to facilitate the de novo formation of 
other prions to influence cellular phenotypes. The [RNQ+] prion 
itself does not adversely affect the growth of yeast, but the 
overexpression of Rnq1p can form toxic aggregated structures 
that are not necessarily prions. The [RNQ+] prion is also involved 
in dictating the aggregation and toxicity of polyglutamine 
proteins ectopically expressed in yeast. Thus, the [RNQ+] prion 
provides a tractable model that has the potential to reveal 
significant insight into the factors that dictate how amyloid 
structures are initiated and propagated in both physiological 
and pathological contexts.
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(reviewed in refs. 4–6). Hence, elucidating how amyloid struc-
tures form and propagate is critical to understanding disease 
pathogenesis and determining how this type of folded structure 
can have a physiological function.
Much information regarding amyloid formation has been 
gleaned from the yeast model system and the range of tools it 
provides. Several unrelated proteins have been demonstrated to 
form prions in yeast. Yeast prions are associated with changes 
in phenotype that are inherited epigenetically, thereby showing 
how amyloid structures can provide a means of regulating cel-
lular functions and phenotypes. Three well-studied yeast prions 
are [PSI+], [URE3] and [RNQ+], form d by the proteins Sup35, 
Ure2 and Rnq1, respectively. When the essential translation ter-
mination factor Sup35p is sequestered into aggregates in [PSI+] 
cells, it alters translation termination and acts as an omnipotent 
nonsense suppressor.7,8 [PSI+] provides growth advantages under 
certain conditions and as such, it is interesting to consider how 
this type of element could impact the ability of yeast to adapt to 
changing environments and ultimately govern the evolution of 
new traits.9-16 When the transcriptional regulator Ure2p forms 
the [URE3] prion, the transcription of genes involved in nitrogen 
catabolism is derepressed.17 This allows the cell to utilize poor 
nitrogen sources in the presence of good nitrogen sources.
In contrast to Sup35p and Ure2p, the physiological function 
of the Rnq1 protein has yet to be determined. The [RNQ+] prion, 
however, is required for the de novo formation of both [PSI+] and 
[URE3], and was originally classified as the [PIN+] element, for 
[PSI+] inducible.18-22 The [RNQ+] prion has been found in wild 
yeast isolates,23,24 suggesting that it might not be detrimental in 
many genetic backgrounds and growth conditions and instead 
may play some functional role. While [PSI+] and [URE3] were 
discovered by phenotype, Rnq1p was identified as a putative 
prion protein by analyzing the yeast proteome for sequences simi-
lar to the glutamine and asparagine (Q/N)-rich prion-forming 
domains (PFDs) of Sup35p and Ure2p.25 These domains are 
defined as the regions that are both necessary and sufficient for 
prion formation.26 Definitive confirmation of the prion prop-
erties of Rnq1p was shown by transforming in vitro generated 
Rnq1p-PFD fibers (purified, recombinant Rnq1p-(132–405)) 
into [rnq-] yeast to convert cells to [RNQ+].27,28 Like other yeast 
prion proteins, as well as those associated with protein confor-
mational disorders, Rnq1p has the propensity to form amyloid in 
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Rnq1p destabilize [RNQ+] propagation,41,42 further supporting 
the notion that this domain is involved in [RNQ+] propagation. 
Interestingly, however, these rnq1 mutants do not disrupt the 
interaction with Sis1p,41 suggesting that the N-terminal region 
may contribute functions beyond interaction with Sis1p. Finally, 
in a screen aimed to identify residues in the Rnq1p-PFD impor-
tant for [RNQ+] propagation, none of the PFD mutants impaired 
[RNQ+] when tested in the context of full-length Rnq1p,43 and 
only one mutation in the PFD that affects [RNQ+] propagation 
has since been found.41 Collectively, these data yield conflicting 
results as to whether the N-terminus of Rnq1p acts as a positive 
or negative regulator in the maintenance of the [RNQ+] prion. 
Elucidating the role of the N-domain will provide insight into 
how other intragenic or non-PFD regions may be involved in the 
formation and propagation of amyloid structures in a pathologi-
cal or physiological setting.
The Rnq1p-PFD is comprised of multiple recognition ele-
ments that act cooperatively. In addition to regions outside of 
the Rnq1p-PFD being involved in [RNQ+] propagation, it seems 
clear that the Rnq1p-PFD is more complex than the PFDs of 
Sup35p or Ure2p. The Sup35p-PFD, for example, is much smaller 
(aa 1–123) with two defined regions important for [PSI+] propa-
gation: a short Q/N-rich tract (aa 5–27) and a region of clearly 
defined oligopeptide repeats (aa 41–95).33,44 These regions can be 
functionally separated into sequences important for prion forma-
tion and sequences important for prion propagation.45 Likewise, 
the oligopeptide repeats in the mammalian prion protein, PrP, 
are involved in dictating prion infectivity.46-48 In contrast, Ure2p 
does not have any oligopeptide repeats and the Rnq1p-PFD has 
loosely defined oligopeptide repeats among four largely sepa-
rated Q/N-rich regions.26 Hence, the regions that influence the 
propagation and heritability of Rnq1p aggregates remain poorly 
defined. None of the four Q/N-rich regions of the Rnq1p PFD 
is sufficient to maintain [RNQ+].49 The presence of either QN2 
(aa 218–263) or QN4 (aa 337–405) is required, but the presence 
of QN1 (aa 185–198) or QN3 (aa 279–319) strongly enhances 
propagation.49 Thus, the Rnq1p-PFD has multiple sequence 
determinants that cooperate to propagate [RNQ+], thereby creat-
ing a complex, composite PFD with ill-defined roles for each of 
these sequence elements. Defining these roles will help us under-
stand how the primary sequence of a protein is involved in dictat-
ing amyloid formation.
[RNQ+] Propagation Depends  
on Interactions with Chaperones
Differential roles of chaperones on prion propagation. A con-
served network of molecular chaperones helps proteins adopt and 
maintain their proper fold, thereby combating the misfolding and 
aggregation of proteins that can cause disease.50 Chaperones also 
play a major role in the propagation of all yeast prions.51-53 Proteins 
in the Hsp40 and Hsp70 families deliver aggregated substrates to 
the disaggregase Hsp104p for resolubilization.54,55 This process 
serves to fragment prion aggregates into seeds that can be effi-
ciently transmitted from mother to daughter cells during mito-
sis.56-58 Both Hsp104p and the essential Hsp40 Sis1p are required 
vitro with parallel in-register cross-β-sheets.29 Strikingly, prion 
proteins can form several unique prion variants (or strains) that 
have slight differences in their β-sheet structure that constitute 
distinct amyloid conformations.30,31 Such different structures are 
presumably the underlying cause of the diverse phenotypic varia-
tion seen in both yeast and in prion diseases.22,32-34 In the case of 
Rnq1p, several different [RNQ+] variants have been described, 
and these correspond to different levels to which they facilitate 
the formation of [PSI+].22
In this review, we summarize the properties and protein 
interactions of the [RNQ+] prion and highlight its similarities 
and differences to other yeast prions. This discussion provides a 
framework to study how [RNQ+] may represent another example 
of a functional amyloid. In addition, we describe how [RNQ+] 
can be used to model pathological amyloid, thereby showing how 
the same protein may form both toxic and non-toxic aggregates.
The PFD of Rnq1p is Complex  
and May Not be Confined to the Q/N-Rich Region
The N-domain of Rnq1p may be involved in [RNQ+] main-
tenance. While most polypeptides may be able to form amy-
loid structures given the right conditions, there are a number of 
intrinsic factors that determine whether a protein will aggregate 
under physiological conditions in vivo.35 A high degree of hydro-
phobicity, minimal net charge, and an intrinsically disorder d 
region often contribute to the propensity of many amyloido-
genic proteins, such as PrP and the Alzheimer disease protein 
Aβ, to form β-sheets and aggregate.1 In contrast, polyglutamine 
(polyQ) proteins are characterized by having a long, highly polar 
stretch of glutamine residues.36 The PFDs of many yeast prion 
proteins are similarly polar as they are enriched in glutamines 
and asparagines.26 Thus, our understanding of how amino acid 
composition influences aggregation and amyloid formation is 
incomplete.
The PFD of Rnq1p was initially defined as the C-terminal 
Q/N-rich region (aa 153–405) by sequence analysis using the 
PFDs of Sup35p and Ure2p, and this was later verified experi-
mentally.25 The N-terminal domain (aa 1–152) of Rnq1p, on the 
other hand, has no known function. To better understand the 
regions of Rnq1p that are important for [RNQ+] propagation, the 
effect of a series of RNQ1 truncations on [RNQ+] propagation 
was tested.37 With the exception of one construct (aa 172–405) 
that transmitted [RNQ+] more efficiently than the entire PFD 
(aa 133–405 in this case), the efficiency of propagation decreased 
with decreasing fragment lengths. This result provided the first 
indication that, in addition to the PFD, the N-domain may be 
involved in maintenance of the [RNQ+] prion.
Other studies have also revealed a potential role for the 
N-domain in the propagation of [RNQ+]. An interaction between 
Rnq1p and the Hsp40 Sis1p is required for [RNQ+] propagation.38 
Mutation of one residue in Rnq1p in the putative Sis1p binding 
site (L94A) disrupts this interaction and eliminates the [RNQ+] 
prion.39,40 This suggests that the N-terminus of Rnq1p facilitates 
the interaction with Sis1p to maintain [RNQ+]. Additionally, 




required for [RNQ+] propagation: two point mutations in this 
region (N108I and D110G) impair maintenance of [RNQ+].65 
Interestingly, in vitro, Sis1ΔG/F can still bind substrates and 
stimulate ATPase activity of the Hsp70 Ssa1p,69 which can inter-
act with Rnq1p.38 This suggests that these functions of Sis1p are 
dispensable for [RNQ+] propagation, thereby making it unclear 
as to how Sis1p mediates propagation of [RNQ+]. Moreover, 
downregulation of Sis1p or Hsp104p cures [RNQ+] by increasing 
the size of Rnq1p aggregates in [RNQ+] cells64 beyond a certain 
threshold that can be effectively transmitted to daughter cells.70 
Perplexingly, the overexpression of Ssa1p also causes an increase 
in Rnq1p aggregate size.71 Thus, the chaperone dynamics 
involved in fragmenting Rnq1p aggregates to propagate [RNQ+] 
are still poorly defined.
[RNQ+] as a Functional Amyloid: A Two-Prion System 
to Regulate the Formation of New Heritable Traits
Discovery of [PIN+]. Before Rnq1p was recognized to form the 
[RNQ+] prion,25 it was discovered that the de novo formation of 
[PSI+] depended on the presence of [PIN+], a non-Mendelian fac-
tor that was presumed to be a prion.18,19 It was later found that 
[RNQ+] was the [PIN+] element and that while Δrnq1 cells main-
tained [PSI+], the de novo formation of [PSI+] did not occur in 
Δrnq1 cells.20,21 Overexpressing other Q/N-rich proteins can also 
confer the Pin+ phenotype by e hancing the formation of [PSI+], 
but [RNQ+] does so most efficiently and does not require the over-
expression of RNQ1.20,72 Once [PSI+] has formed, both [RNQ+] 
and [PSI+] can propagate independently,19,73 and the presence of 
[RNQ+] does not affect [PSI+]-mediated nonsense suppression 
nor most [PSI+]-dependent phenotypes.19 This was the first pub-
lished example of a productive interaction between heterologous 
prions.74 It is interesting, then, to consider the biological con-
sequences of [RNQ+] and its influence on [PSI+]. The presence 
of the [PSI+] prion has profound phenotypic effects and confers 
growth advantages in certain conditions.9,75,76 Not surprisingly, 
the reduced efficiency of translation termination can also be det-
rimental.9,76 Different [PSI+]-mediated phenotypes are observed 
in different genetic backgrounds.9,76 Even different stocks of the 
same strain can show different phenotypes: for instance, different 
stocks of the strain 74-D694 show phenotypic variation and some 
have even lost the ability to recover from stress (refs. 9 and 76 and 
unpublished data). These differences highlight the complexity of 
many of these phenotypes and are partly due to additional muta-
tions, but unfortunately, this has been referred to as conflicting 
evidence for the potential of [PSI+] to be beneficial.77,78 Yet, the 
molecular nature of some [PSI+]-dependent phenotypes has been 
elucidated.76,79 As these traits depend on the ability of [PSI+] to 
act as an omnipotent nonsense suppressor, it has been proposed 
that [PSI+] provides an epigenetic means for adapting to chang-
ing environments.9-11 It is currently unclear whether [PSI+] exists 
in wild strains, as the primary method used to assay for [PSI+] 
in wild strains (Sup35-PFD-GFP aggregation23) is inconclusive 
as it typically requires the presence of both [PSI+] and [RNQ+]. 
For example, some [PSI+] [rnq-] “BSC” strains (Cox and Tuite11) 
do not show fluorescent foci when expressing Sup35-PFD-GFP 
for the propagation of [PSI+], [URE3] and [RNQ+].25,38,59-61 
Several lines of evidence, however, suggest that these chaper-
ones may be differentially involved in propagating these prions. 
[PSI+], [URE3] and [RNQ+] show distinct sensitivities to both 
expression levels and mutation of Sis1p and Hsp104p.40,60,62,63 The 
overexpression of Hsp104p eliminates [PSI+], but does not affect 
propagation of [RNQ+] or [URE3].8,38,59,61 In contrast, [RNQ+] 
and [URE3] are more sensitive to Sis1p levels than [PSI+]. Sis1p 
overexpression does not affect [RNQ+] propagation,38 but when 
Sis1p is downregulated, both [RNQ+] and [URE3] are lost within 
20 generations as compared to >60 generations that it takes to 
lose [PSI+].60,64 When Hsp104p is inhibited by guanidine hydro-
chloride, though, the rate of loss is similar for all three prions and 
is comparable to the loss of [RNQ+] and [URE3] when Sis1p is 
downregulated.60 One possible explanation as to why these pri-
ons show different sensitivities to Sis1p is that one of the other 
12 Hsp40s present in yeast could partially compensate for Sis1p 
in [PSI+] propagation. However, none of the other Hsp40s are 
required for propagation of [PSI+], [URE3] or [RNQ+].60,65 Besides 
Sis1p, the only other Hsp40 shown to bind Rnq1p is Ydj1p.65,66 
Ydj1p is dispensable for [RNQ+] propagation,65 but the overex-
pression of Ydj1p cures some variants of [RNQ+].22 Such differ-
ences in chaperone requirements of [RNQ+], [PSI+] and [URE3] 
may indicate that the structural differences between different 
prions and/or variants are responsible for dictating how chaper-
ones recognize or fragment prion aggregates. Our understanding 
of this highly specific interplay between molecular chaperones 
and prions is far from complete. Additional mechanistic studies 
are required to better understand how chaperones regulate prion 
propagation—an understanding that could lead to therapeutic 
development for protein conformational disorders.
Sis1p and [RNQ+] propagation. Sis1p binds Rnq1p in equi-
molar ratios in [RNQ+] cells and this interaction is required for 
[RNQ+] propagation.38-40,65 Both the human homolog of Sis1p, 
HDJ1, and the Drosophila homolog, DROJ1, can compensate for 
the loss of Sis1p in viability and [RNQ+] propagation, suggesting 
a conserved function of Sis1p acts in prion propagation.65 The 
sequences of Class I and Class II Hsp40s were compared to ana-
lyze the specificity of Sis1p in prion propagation.65 Both types of 
Hsp40s have an N-terminal J-domain that mediates their inter-
action with Hsp70s and stimulates Hsp70 ATPase activity.67 A 
glycine-rich region is adjacent to the J-domain in both classes 
as well. In Sis1p, this domain is divided into two parts: a G/F 
domain rich in glycine and phenylalanine residues and a G/M 
domain rich in glycine and methionine. The function of these 
domains is unclear. Following the glycine-rich domain, Class I 
Hsp40s have a cysteine-rich domain that is not present in Class II 
Hsp40s like Sis1p. Lastly, both classes have a C-terminal domain 
(CTD) that can bind unfolded substrates in vitro.68 The G/F 
domain is the most critical part of Sis1p in [RNQ+] propagation 
as its deletion eliminates [RNQ+], although the G/M domain 
and the CTD are also likely to be involved as deletion of these 
domains alters aggregates of Rnq1p.38 The dependence of [RNQ+] 
on the G/F domain helps explain the specificity of Sis1p, as this 
region is fairly unique among Hsp40s. The region of aa 101–113 
in the Sis1p G/F domain is not present in other Hsp40s, and is 
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there is no correlation with the size and distribution of Rnq1p 
aggregates as there is for [PSI+] variants: medium [RNQ+] and 
very high [RNQ+], for instance, exhibit nearly identical aggregate 
distributions.73,82 Another means of categorizing [RNQ+] variants 
is based on the aggregation pattern seen in [RNQ+] cells express-
ing Rnq1p-GFP: single dot (s.d.) for a single focus of fluorescence, 
or multi dot (m.d.) for cells having multiple foci.88 Curiously, the 
relationship between [RNQ+] and [URE3] does not follow the 
same trend as [RNQ+] and [PSI+]. All of the s.d. [RNQ+] variants 
induce [URE3] similarly, while m.d. high [RNQ+] is unique and 
has the highest level of [URE3] formation.22 This suggests that 
[RNQ+] interacts differently with Sup35p and Ure2p to promote 
prion formation. Further investigation of these heterologous 
prion interactions will help elucidate one means by which prion 
variants can form de novo.
Models of [RNQ+]-mediated [PSI+] formation. Two predom-
inant models have been proposed to explain how [RNQ+] facili-
tates the formation of the [PSI+] prion.20,21 The titration model 
postulates that in [rnq-] cells, some factor prevents the forma-
tion of [PSI+], but the [RNQ+] prion sequesters this inhibitor to 
allow for conversion to [PSI+].20,21 Alternatively, the cross-seeding 
model proposes that the Rnq1p aggregates in [RNQ+] cells physi-
cally interact with Sup35p and serve as an imperfect template 
for [PSI+] formation.20,21 While these models are not mutually 
exclusive, no inhibitor has been found to date, even though much 
work has been directed toward this goal.20 Additionally, in sup-
port of a physical interaction between Rnq1p and Sup35p, fibers 
of recombinant Rnq1p can seed the amyloid formation of recom-
binant Sup35p, albeit inefficiently, and Rnq1p and Sup35p have 
been shown to occasionally colocalize.72,89 Furthermore, rnq1 
mutations have been identified that have no detectable effect 
on the structure of Rnq1p aggregates, but impair the formation 
of [PSI+], suggesting that these residues may physically interact 
with Sup35p to induce [PSI+].43 Of course, these findings do not 
exclude the possibility that some cofactor is also involved in this 
process. Nevertheless, such cross-seeding or co-aggregation of 
amyloidogenic proteins may play a role in sporadic protein con-
formational disorders and this model provides the framework to 
understand how that may occur.
Non-productive amyloid interactions. In addition to facili-
tating prion formation, [RNQ+] is involved in seemingly “non-
productive” prion interactions, the purpose of which is unclear. 
For example, [RNQ+] can induce formation of Sup35p aggre-
gates that are not [PSI+], termed non-heritable amyloid.90 Unlike 
[PSI+], which propagates independently after induction, the over-
expression of Sup35p and continuous interaction with [RNQ+] 
are required to maintain these non-heritable aggregates, which 
may represent by-products of [PSI+] formation. Additionally, the 
presence of [PSI+] can enhance the formation of [RNQ+].20
Interestingly, [URE3] and [PSI+] can antagonize each other.91 
Shortly after that discovery, it was paradoxically found that cer-
tain [RNQ+] and [PSI+] variants are incompatible.88 For example, 
s.d. [RNQ+] variants destabilize weak [PSI+] by increasing the size 
of Sup35p aggregates.71,88 Such destabilization was not seen for 
the m.d. high [RNQ+] variant. This relationship was reciprocal 
for the s.d. medium [RNQ+] and s.d. very high [RNQ+] variants, 
(True and Lindquist, unpublished data). Nevertheless, the exis-
tence of [PSI+] in the wild would be predicted to be transient 
and may not easily survive the switch to laboratory cultivation. 
Since [RNQ+] is required for [PSI+] to form and is present in wild 
yeast isolates,23,24 it follows that the [RNQ+] prion may serve to 
poise cells to form [PSI+] when environmental conditions change. 
In this way, this two-prion system may regulate translation and 
the ability of yeast to quickly adapt by using otherwise unavail-
able genetic information. More recently, it was discovered that 
[RNQ+] is also required for the formation of [URE3].22,80 [URE3] 
regulates nitrogen catabolism and may provide growth advan-
tages in high concentrations of certain ions.81 As such, the pres-
ence of [RNQ+] may allow the cell to adapt to environmental 
changes and utilize a variety of nitrogen sources. Further exami-
nation of these interactions may eventually establish the [RNQ+] 
prion as a functional amyloid.
[RNQ+] exists in different aggregated structures. Distinct 
aggregated structures of the mammalian prion protein, PrP, form 
unique prion strains that dictate disease transmissibility and are 
thought to be the underlying cause of much of the variation in 
the pathology of prion diseases.32 Definitive proof that changes 
in amyloid conformation can cause phenotypic variation came 
from studies of [PSI+] prion variants. Weak [PSI+] variants are 
characterized by lower levels of nonsense suppression and have 
aggregates that are larger, more stable, and show a slower rate of 
amyloid formation as compared to fibers that form strong [PSI+] 
variants.31,82-84 A model was proposed to explain the molecular 
basis of prion variants, positing that fiber stability and the kinet-
ics of amyloid formation were the two primary determinants 
of the prion variant that propagated.85 In contrast, for [RNQ+] 
variants similarly formed from transforming in vitro fibers, only 
fiber stability correlates with the proposed model: aggregates of 
weaker [RNQ+] variants are more stable, but exhibit a faster rate 
of fiber formation.28 This suggests that the factors that determine 
the physical basis of [RNQ+] variants may not be the same as 
those that define [PSI+] variants.28,85 Elucidating how different 
prion variants form and propagate is critical to understanding 
how different aggregated structures can modulate disease pathol-
ogy. Indeed, even with one prion protein, different mechanisms 
may act to generate different classes of prion strains. Strains 
formed with PrP, for instance, do not all fit into one simple model 
that correlates biochemical and biophysical properties to in vivo 
propagation.86,87
Interestingly, the de novo appearance of [PSI+] not only 
depends on the presence of [RNQ+], but also on the prion variant 
of [RNQ+]. [RNQ+] variants were initially classified by how well 
they induce [PSI+]. [PSI+] is induced at a low frequency with the 
low [RNQ+] variant, and increasing levels of [PSI+] induction are 
seen with the medium, high and very high [RNQ+] variants.22 
This classification only partly correlates to the level of aggregated 
Rnq1p, with decreasing levels of soluble Rnq1p seen from the 
low [RNQ+] to the high [RNQ+] variant. The very high [RNQ+] 
variant was an outlier and showed the most soluble Rnq1p of the 
[RNQ+] variants.22 This change in solubility of the Rnq1 protein 
in these variants is often difficult to detect,40 however, and not 




vitro.97 The role of these chaperones in dictating polyQ aggrega-
tion and toxicity is linked to their role in propagating the [RNQ+] 
prion: both deletion of RNQ1 and curing of [RNQ+] suppress 
polyQ aggregation and its associated toxicity.95 This also corrob-
orated earlier findings that Pin+ factors enhance the formation of 
polyQ aggregates.21
[PSI+] also enhances polyQ toxicity and has an additive effect 
when [RNQ+] is present,96 although most yeast models of polyQ 
aggregation show a stricter dependence on [RNQ+]. In a recipro-
cal fashion, polyQ aggregates can induce aggregation (though 
not prion formation) of both Rnq1p and Sup35p,98,99 thereby 
showing how co-aggregation of polyQ and/or Q/N-rich proteins 
may play a major role in disease pathogenesis. Similarly, while 
sequences flanking the expanded polyQ repeats can modulate 
this toxicity, these sequences have the same effect when expressed 
in trans, and other Q-rich proteins also influence polyQ toxic-
ity.100,101 Importantly, however, all of these effects rely on the pres-
ence of the [RNQ+] prion.
Insight into how Rnq1p modulates polyQ aggregation and 
toxicity came from the observation that mutations in endocytic 
proteins enhance toxicity in a [RNQ+]-dependent manner.102 
PolyQ aggregates partially sequester the endocytic machinery and 
actin, thereby inhibiting endocytosis. This defect was also seen in 
mammalian cells.102 It was later discovered that proteins associ-
ated with the late stages of the maturing endocytic complexes are 
recruited nto polyQ aggr gates.103 This co-aggregation is most 
likely due to the polyQ stretches present in many endocytic pro-
teins. Similarly, Rnq1p and multiple chaperones also associate 
with aggregates of polyQ protein in [RNQ+] cells.100,102,104 These 
protein interactions may help initiate polyQ aggregation, and the 
Q/N-rich Rnq1p aggregates in [RNQ+] cells might template this 
process. Since Rnq1p has no known mammalian homolog, how-
ever, it is unclear whether a similar mechanism occurs in human 
disease. Nevertheless, the yeast model of polyQ aggregation pro-
vides a means of determining candidate proteins that may be 
involved in either suppressing or enhancing polyQ toxicity, and 
thereby provides a viable approach to identify novel therapeutic 
targets.105 As such, the strict dependence of polyQ aggregation on 
the [RNQ+] prion shows how [RNQ+] can aid in studying patho-
logical amyloid.
Rnq1p overexpression is toxic in [RNQ+] cells. In addition to 
its role in facilitating polyQ toxicity, it was shown that the over-
expression of Rnq1p in [RNQ+] cells can also result in gain-of-
function toxicity.39 This toxicity required strong overexpression 
of full-length Rnq1p, as overexpression of either the PFD or the 
N-domain alone was not toxic. Overexpression of Sup35p in [PSI+] 
cells can also be toxic.33 In this case, it is clear that the essential 
termination complex is sequestered into [PSI+] aggregates and the 
toxicity is rescued by overexpression of Sup35p’s binding partner, 
Sup45p.106,107 Analogously, the overexpression of Sis1p suppresses 
the toxicity of Rnq1p overexpression.39 This rescue depends on 
the translocation of Rnq1p into the nucleus, resulting in increased 
Rnq1p aggregate formation.108 Perhaps through a very different 
mechanism, overexpressing Rnq1p-L94A in [RNQ+] cells is also 
toxic. Sis1p overexpression does not suppress the L94A-induced 
toxicity since this mutant impairs the Rnq1p-Sis1p interaction.39 
as the cells that did not form unstable [PSI+] converted to [rnq-] 
instead. This incompatibility was also seen with newly-induced 
[PSI+]: after inducing the formation of strong [PSI+], 70% of s.d. 
medium [RNQ+] cells and 37% of s.d. very high [RNQ+] cells 
became [rnq-].88 Furthermore, all s.d. medium [RNQ+] cells that 
had stably acquired weak [PSI+] became [rnq-]. The mechanism 
behind these incompatible or non-productive prion interactions 
is unknown, but this may reveal how some protein aggregates can 
cap other aggregates or compete for cellular resources.
Mutations in RNQ1 have also been found to negatively affect 
[PSI+] propagation. Deletion of the first 100 amino acids of 
Rnq1p (Rnq1pΔ100) was found to inhibit the propagation of 
strong [PSI+].92 Overexpression of the Rnq1Δ100 protein elimi-
nated both weak and strong [PSI+] in a [RNQ+]-dependent man-
ner, regardless of any particular [RNQ+] variant. Additionally, 
Rnq1pΔ100 inhibits [URE3] propagation and reduces the toxic-
ity of polyQ aggregates.92 Rnq1pΔ100 was later classified as a 
prion ([RNQ1Δ100+]) that induces [PSI+], but the Rnq1pΔ100-
mediated induction then results in the loss of either [RNQ1Δ100+] 
or [PSI+].93
Most recently, 23 point mutations within the N-terminus 
of Rnq1p were uncovered that are phenotypically similar to 
Rnq1pΔ100.42 The overexpression of these mutants resulted in 
the [RNQ+]-dependent elimination of [PSI+] by increasing the 
size of Sup35p aggregates.42 Interestingly, when expressed from 
the native RNQ1 promoter, these mutants did not affect [PSI+], 
but impaired [RNQ+] propagation.41,42 Most of these mutations 
map to the putative α-helical domains of Rnq1p, and while 
the authors propose that these regions are involved in facilitat-
ing protein-protein interactions, the mechanism underlying the 
antagonistic prion interactions is unclear. One possibility is that 
disrupting the structure of the N-terminus may cause a gain-of-
function effect through non-productive interactions with Sup35p 
that may result in capping to cure [PSI+]. However, one can only 
speculate how these seemingly non-productive prion interactions 
relate to the potential role that [RNQ+] may play in inducing 
[PSI+] as a means of adapting to fluctuating environments. It is 
feasible, for example, that the incompatibility between certain 
protein conformers serves as a binary switch to regulate [PSI+]-
mediated adaptation.
[RNQ+] as a Model for Pathological Amyloid
polyQ aggregation depends on [RNQ+]. A number of inherited 
human diseases are caused by the expansion of glutamine repeat 
sequences beyond a certain threshold in particular proteins.36 
These expanded polyQ proteins are prone to aggregation that is 
associated with cytotoxicity and leads to neurodegeneration and 
ultimately death. Yeast models were created to provide a trac-
table means of studying the aggregation mechanisms of these 
proteins.94-96 Interestingly, the overexpression of the chaperones 
intimately involved in prion maintenance (Sis1p, Hsp104p and 
Hsp70s) modulated aggregation of the huntingtin (Htt) protein 
that had a pathological polyQ expansion.94 Deletion of HSP104 
effectively eliminated aggregation. The importance of these 
chaperones in regulating polyQ aggregation was also validated in 
©2011 Landes Bioscience.
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Conclusions
While the term amyloid is generally associated with the proteins 
that aggregate in protein conformational disorders, there are an 
increasing number of examples of amyloid structures having a 
functional role in normal biology.4,5 Clearly, some amyloidogenic 
proteins have the potential to form both toxic and non-toxic 
structures. From a structural standpoint, this is best detailed 
with the prion protein Het-s in the filamentous fungi Podospora 
anserina. Structures of Het-s associated with toxicity are amy-
loids having antiparallel β-sheets, whereas the benign structures 
identified form parallel β-sheets.111 Similarly, the [RNQ+] prion 
may simultaneously serve as an example of a functional amyloid 
and as a model for understanding pathological amyloid, thereby 
allowing us to examine a number of questions relevant to either 
a physiological or disease context: What is the toxic protein con-
former? How are protein aggregates toxic? What types of het-
erotypic interactions do amyloidogenic proteins have? How can 
a single protein form different aggregated structures? How do 
these various structures cause changes in phenotype? Studying 
these questions using the [RNQ+] prion will further our under-
standing of protein conformational disorders and perhaps also 
explain why evolution has preserved proteins that are susceptible 
to toxic conversion. Indeed, there are examples in biology of bal-
ancing selection, in which a certain trait has been conserved even 
though it is associated with disease, such as the sickle cell trait 
providing some resistance to malaria.112,113
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Interestingly, Rnq1p-L94A overexpression is also toxic in [rnq-] 
cells, which can be attributed to its ability to form “off-pathway” 
aggregates in the absence of [RNQ+]. As seen for wild-type Rnq1p, 
however, directing Rnq1p-L94A to the nucleus via the addition of 
a nuclear localization signal suppresses toxicity.108 Furthermore, 
nuclear Rnq1p aggregates can act in trans to sequester Rnq1p 
from the cytosol and repress toxicity. It has been proposed that 
Rnq1p overexpression causes the accumulation of an off-pathway, 
toxic aggregate in the cytoplasm, but the nucleus provides an 
environment for more efficient formation into benign aggregates. 
These nuclear aggregates can also localize polyQ to the nucleus.108 
Yet, instead of suppressing toxicity, nuclear translocation of polyQ 
enhances toxicity by decreasing the formation of SDS-resistant 
polyQ aggregates.108 Hence, while the nucleus may provide a bet-
ter environment for the formation of a benign amyloid structure 
for Rnq1p, the nuclear environment renders polyQ more soluble 
and more toxic.
Ydj1p has also been shown to modulate Rnq1p-associated tox-
icity. Overexpression of the Rnq1p-PFD is toxic in Δydj1 [RNQ+] 
cells, even though it is not toxic in wild-type cells.66 In contrast to 
full-length Rnq1p, this toxicity is associated with the formation 
of SDS-resistant aggregates. The expression of Ydj1p was sug-
gested to suppress this toxicity by binding to the Rnq1p-PFD and 
limiting the pool of aggregates. This suppression requires sev-
eral features of Ydj1p: the zinc finger-like region (ZFLR) that is 
implicated in transfer of substrates to Hsp70s,109 the C-terminal 
domain 1 (CTD1), which contains a hydrophobic peptide-bind-
ing pocket,110 and farnesylation of the CAAX box.66 Interestingly, 
these same domains were required for the Ydj1p-dependent sup-
pression of polyQ toxicity.66 These common mechanisms high-
light the utility of Rnq1p as a model to further investigate the 
cellular machinery that regulates proteotoxicity. Additionally, 
these models may help to determine what types of protein con-
formers are toxic to cells.
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